Immunocore Holdings PLC expected to post breakeven results a share - Earnings Preview

Immunocore Holdings

27/02/2023 13:41

* Immunocore Holdings PLC  IMCR.OQ   IMCR.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 1. 
    * The Abingdon Oxfordshire-based  company is expected to
report  a
549.6% increase in revenue to £42.826 million from £6.59 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Immunocore Holdings
PLC
is for breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunocore
Holdings PLC is $81​, above​ its last closing price of $55.01.
​​​

Previous quarterly performance (using preferred earnings measure
in pounds). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.22       -0.29      0.12      Beat    141.7
 Jun. 30 2022  -0.59       -0.67      -0.14     Beat    79.1
 Mar. 31 2022  -0.82       -0.84      -0.37     Beat    56.2​
 Dec. 31 2021  -0.80       -0.82      -0.91     Missed  -10.9
 ​​Sep.        -0.75       -0.63      -0.68     Missed  -8.1
 30 2021                                                
 Jun. 30 2021  -0.69       -0.68      -0.74     Missed  -7.8​
 Mar. 31 2021  -0.59       -0.59      -0.66     Missed  -12.5
 Dec. 31 2020  -0.76       -0.76      -0.62     Beat    22.4
 This summary was machine generated February 27 at 13:41 GMT. 
All figures in pounds  unless otherwise stated